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Abstract
Aims and objectives Children suffering from intestinal failure (IF) endure considerable morbidity and overall have poor 
survival rates, complicated by the shortage of organs available for transplantation. Therefore, new therapeutic approaches 
are pivotal if outcomes are to be improved. Over the past years, tissue engineering (TE) has emerged as a possible alternative 
treatment for many congenital and acquired conditions. TE aims at creating bioengineered organs by means of combining 
scaffolds with appropriate cell types, which in the intestine are organised within a multilayer structure. In order to generate 
functional intestine, this cellular diversity and organisation will need to be recreated. While the cells for the epithelial, neural 
and vascular compartments have been well defined, so far, less attention has been put on the muscular compartment. More 
recently, mesoangioblasts (MABs) have been identified as a novel source for tissue regeneration since they are able to give 
rise to vascular and other mesodermal derivatives. To date MABs have not been successfully isolated from intestinal tissue. 
Therefore, our aim was to demonstrate the possibility of isolating MABs from adult mouse small intestine.
Materials and methods All experiments were carried out using small intestinal tissues from C57BL/6J mice. We applied 
an established protocol for MAB isolation from the isolated neuromuscular layer of the small intestine. Cultured cells were 
stained for Ki67 to assess proliferation rates as well as for a panel of pericyte markers to determine their phenotype.
Results Cells were successfully isolated from gut biopsies. Cultured cells showed good proliferative capacity and positivity 
for at least three pericytes markers found in vessels of the gut neuromuscular wall: neuron-glial antigen 2, alkaline phos-
phatase and platelet-derived growth factor β.
Conclusion This proof-of-principle study lays the foundation for further characterization of MABs as a possible cell source 
for intestinal smooth muscle regeneration and TE.
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Introduction
The gastrointestinal tract (GI) is a complex physiological 
system composed of many organs. Its main function is to 
fulfil the nutritional demands of the body by processing 
food and eliminating waste, thanks to a muscular gut wall 
that mixes and moves luminal contents along the tubular 
organs [1]. When intestinal capacity to fulfil nutritional 
demands becomes insufficient and parenteral nutrition is 
needed, intestinal failure (IF) occurs [2]. IF afflicts ten of 
thousands of children worldwide [3] but with an overall 
mortality rate of around 25%, mainly due to multi-organ 
system failure, sepsis, haemorrhage caused by prolonged 
parenteral nutrition and complications associated with 
intestinal transplantation [4]. IF remains the primary indi-
cation for intestinal transplantation in children, particu-
larly related to short bowel syndrome or gastrointestinal 
motility disorders [5]. Unfortunately, small bowel trans-
plantation is still a very challenging approach: in children, 
isolated small bowel transplantation has shown very high 
incidence of acute rejection, up to 45% within the first 
two years, with a small reduction (around 35–38%) when 
multi-organ transplantation is performed [5]. Furthermore, 
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the paucity of available, correctly sized organs for chil-
dren, along with the necessity of life-long immunosuppres-
sion, poses additional obstacles. In this context, a tissue 
engineering (TE) approach could provide an alternative 
strategy to small bowel transplantation with the potential 
to overcome organ donor shortages and the necessity of 
life-long immunosuppression [6]. To generate a functional 
intestine with a TE approach, two critical steps need to 
be overcome: the generation of a biocompatible scaffold 
and the isolation, expansion (and subsequent seeding in 
the scaffold) of the different cell types that compose a 
functional intestine.
To date, researchers have attempted to regenerate sev-
eral organs, including the intestine, using decellularised 
scaffolds [7–10]. Totonelli and colleagues have shown that 
decellularised intestine maintains critical intestinal extra-
cellular components and reported epithelial cell adherence 
and preservation of angiogenic properties of decellularised 
scaffolds [9]. In regards to specific cellular components, 
the primary focus of recellularisation studies have been 
both the epithelial and vascular compartments as reported 
by Kitano et al., where intestinal organoids were used for 
the regeneration of a functional intestinal mucosa [8]. Less 
attention has been placed on the neuromuscular compart-
ment with few studies reporting on the use of neural crest 
cells derived from induced pluripotent stem cells [11, 12]. 
Indeed, there have been no reported studies focussed on 
the muscular compartment in itself, highlighting the need 
for research into this under-represented, but critical, cell 
type for intestinal regeneration.
Recently, pericytes have been identified as a powerful 
cell source for tissue regeneration [13]. In fact, pericytes, 
specialised cells of the vessel mural wall defined by their 
position underneath the basal lamina of micro-vessels, 
have been indicated as multipotent stem/progenitor cells 
that resemble mesenchymal stem cells [14–17]. Amongst 
them, a group of cells able to give rise to vascular and 
other mesodermal derivatives in vivo [18] have been iden-
tified and termed mesoangioblasts (MABs). When derived 
from adult tissue, MABs lose endothelial properties but 
maintain features of pericytes, suggesting that they can 
be referred as pericyte-derived cells. The role of MABs 
as a tool for tissue regeneration has very recently been 
confirmed by Urbani et al., who showed that human MABs 
derived from skeletal muscle biopsies can contribute to the 
regeneration of the neuromuscular wall of bioengineered 
oesophagus [10]. It is therefore possible that the gut mus-
culature may regenerate via a perycite-control mechanism. 
In this perspective, isolation of MABs from the intestine 
could improve the efficiency of muscular intestinal regen-
eration. The aim of this study was to test the possibility 
of isolating MABs from the musclular wall of the murine 
small intestine.
Methods
Mouse small intestine dissection
Small intestines were dissected from C57BL/6J mice, 
obtained from The Jackson Laboratory (Bar Harbor, MN, 
USA) after cervical dislocation. Animal house facilities 
were compliant with the UK Home Office Certificate of 
Designation and all animals used in the experiments were 
kept in conformity with the UK Animals Act 1986 and 
approved by the University College London Biological 
Services Ethical Review Process.
Cells isolation
Cells were isolated with adaptations from the protocol 
published by Tonlorenzi et al. [19]. Following washes 
with sterile phosphate buffer saline (PBS, Gibco), smooth 
muscle layers of the small intestine were carefully dis-
sected from the submucosal and mucosal layers, using 
fine forceps under a stereomicroscope. The intestine was 
opened and pinned out onto a  Sylgard® coated plate filled 
with PBS supplemented with 1% v/v Pen-Strep (Gibco) 
to prevent bacterial infection. Subsequently, the mucosa 
was delicately separated from the neuromuscular layer, 
which was then cut into 2 mm2 wide pieces. These pieces 
were transferred into 6-well dishes, pre-treated with 1% 
v/v growth factor reduced Matrigel™ (MRF, BD) to favour 
attachment and cell outgrowth, with a maximum of three 
pieces per well. Enriched Megacell medium (Sigma) was 
gently added, to avoid fragment detachment, until the 
muscle pieces were covered. Dishes were placed inside a 
humidified chamber and placed in an incubator at 37 °C, 
5%  CO2, 5%  O2. The following day, fresh medium was 
added on each well.
Every 2 days, cultures were checked for preliminary 
growth and the medium was changed. After 6–10 days, 
according to the level of cell outgrowth, cells were trypsi-
nized and placed into flasks. The medium composition for 
cell outgrowth and expansion was prepared by enriching 
Megacell with 5% v/v foetal bovine serum (FBS, Gibco), 
1% v/v non-essential amino acids (Gibco), 1% v/v L-glu-
tamine (Gibco), 1% v/v Pen-Strep (Gibco), 0.05  mM 
β-mercaptorthanol (Sigma) and 5 ng/ml basic-Fibroblast 
Growth Factor (Peprotec).
For cell expansion, when cells reached 60–70% con-
fluency, they were detached, always recovering both the 
adherent and the floating population. After gentle rinsing 
with PBS, trypLE™ (Thermo Scientific) was added and 
incubated at 37 °C for 3 min, when all cells detached from 
the flask and split at approximately 1:5.
Pediatric Surgery International 
1 3
Immunostaining
Cells and intestinal cryosections (10µm thick) were fixed for 
8 min with 4% w/v paraformaldehyde solution (PFA, Sigma) 
and subsequently washed with PBS. Cell permeabilization 
and blocking were performed with 1% w/v Bovine Serum 
Albumin (BSA, Sigma)/0.1% v/v Triton-X in PBS for 1 h 
at room temperature. Samples were incubated overnight at 
4 °C with primary antibodies (Table 1) diluted in 1% w/v 
BSA/ 0.1% v/v Triton-X in PBS, washed three times for 
5 min with PBS and then detected with secondary antibod-
ies (Table 1) diluted in 1% w/v BSA/ 0.1% v/v Triton-X in 
PBS for 1 h at room temperature. Images were taken using 
a Zeiss LSM710 confocal microscope and processed using 
the software ImageJ [20].
Alkaline phosphatase staining
Cells and intestinal cryosections were stained for alkaline 
phosphatase following  Vector® Red protocol  (Vector® Red 
Alkaline Phosphatase Substrate, Vector Laboratories). 
Briefly, a working solution was prepared by mixing Rea-
gent 1, 2 and 3 with the buffer solution: 200 mM Tris–HCl 
(Sigma), pH 8.2–8.5. Samples were incubated with work-
ing solution for 30 min in the dark and then washed three 
times for 5 min with the buffer solution before being counter 
stained with Hoechst (ThermoFisher Scientific) for nuclear 
staining.
Results
In the neuromuscular gut wall, micro-vessels are mainly 
located between the circular and longitudinal muscle layer 
as shown by positivity for CD31, marker of endothelial cells 
(Fig. 1, arrows in right and left panels). As shown in Fig. 1, 
cells positive for neuron-glial antigen 2 and platelet derived-
growth factor β were located in close proximity to CD31 
positive cells (Fig. 1). Additionally, positivity for alkaline 
phosphatase was visible in the same region in between the 
two muscle layers of small intestinal wall (Fig. 1).
Cellular outgrowth from gut muscular biopsies was 
visible after 3–5 days of culture. Triangular shaped cells 
spread out from the intestinal muscle biopsy attached to the 
Matrigel™ reduced factor coated dish (Fig. 2). The cells 
were then passaged and cultured cells after the second pas-
sage had an average percentage of Ki67 positive cells of 
28.6% ± 8% (n = 3 technical replicates).
Cultured cell were then characterised for the expression 
of a range of pericyte markers, which would confirm the 
origin of the isolated cells. Immunostaining of isolated cells 
after 2 passages in culture revealed positivity for neuron-
glial antigen 2 (NG2), positivity for alkaline phosphatase 
Table 1  List of antibodies used
Antigen Host Company Cat. number Concentration
Ki67 Rabbit Abcam ab15580 1:100
PDGFRβ Rabbit Abcam ab32570 1:100
NG2 Rabbit Millipore ab5320 1:100
CD31 Mouse Invitrogen Ma5-13188 1:10
α Rb 488 Goat Invitrogen A-11034 1:500




Fig. 1  Immunoflourescence staining of mouse small intestinal sec-
tions. Muscle layers are located below the dotted lines. CD31 posi-
tive endothelial cells (red, right and left panels) are located between 
the two muscle layers and neuron-glial antigen 2 and platelet-derived 
growth factor β positive cells are localised in close proximity (arrows, 
green). Alkaline phosphatase positive cells in red are localised 
between the two muscle layers (arrowhead). Scale bar = 50 µm
 Pediatric Surgery International
1 3
(ALP) and platelet-derived growth factor β (PDGFRβ: 
Fig. 3).
Discussion
Given the poor survival rate in children with IF together 
with a perpetual shortage of organs available for trans-
plantation, alternative therapeutic approaches are vital for 
the treatment of this devastating condition if outcomes 
are to be improved. Recent advances in the fields of stem 
cell research and bioengineering have demonstrated the 
possibilities for tissue engineered organs in a number of 
systems [7, 8, 10, 21]. Indeed, development of a bio-engi-
neered oesophagus for the possible treatment of oesopha-
geal atresia and other acquired damages to the oesophagus 
may be possible thanks to MABs, which are capable of 
driving smooth muscle regeneration [10]. However, while 
tissue engineering may provide a mechanism of producing 
small-scale segments of recellularised tissue for transplan-
tation, the development of large-scale functional segments 
of intestine for the treatment of IF is daunting. The intes-
tine is a complex structure with absorptive and secretory 
functions that change along the length of the organ. Great 
progress has been made with regards to epithelial regen-
eration with the ability of derive organoid units which 
can be expanded in vitro, and upon differentiation, dem-
onstrate the ability to give rise to regionally specialised 
intestinal epithelial stem cells. Intestinal epithelial stem 
cells can be obtained from intestinal biopsies or resec-
tion and, once isolated, can be maintained in vitro under 
defined culture conditions where they undergo functional 
differentiation and derived crypt-villus organoid structures 
Fig. 2  Cells spreading out from the biopsies (dark shapes at the bottom of the images) onto the plate. Scale bar = 200 µm
Fig. 3  Cultured cells immunostained for neuron-glial antigen 2 (NG2) in green, alkaline phosphatase (ALP) in red and platelet-derived growth 
factor receptor β (PDGFR β) in green. Nuclei were stained with Hoechst in blue. Scale bar = 50 µm
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[22, 23]. Moreover, intestinal epithelial cells can also be 
derived from induced pluripotent stem cells (iPSC) [24].
A different situation is currently found for smooth muscle 
cells. Although smooth muscle cells can be derived from 
biopsies taken from adult intestine, they generally fail to be 
expanded over sequential passages and ultimately undergo 
senescence. It is, therefore, relevant to explore the possibil-
ity of deriving “stem/progenitor” cells of intestinal smooth 
muscle, a critical cellular component of the neuromuscular 
apparatus, which will ultimately be required for functional 
restoration of contractility in any tissue engineered intestinal 
segment.
Recently, mesoangioblasts (MABs), which exist as multi-
potent stem/progenitor cells related to pericytes have been 
suggested as a powerful cell source for tissue regeneration 
[13–17]. When derived from adult tissue, MABs have been 
shown to generate both vascular and other mesodermal 
derivatives [18] including contributing to the regeneration of 
the neuromuscular wall of a bioengineered oesophagus [10]. 
Given this regenerative potential it is possible that MABs 
may provide an ideal cell source for regeneration of intesti-
nal smooth muscle cells. Here, we show that MABs can be 
harvested from adult murine gut and expanded significantly 
maintaining their highly proliferative nature in culture. Both 
of these characteristics offer significant benefits as (1) isolat-
ing MABs from intestinal segments provides an easily acces-
sible source of multipotent stem cells in children with IF and 
(2) the high proliferation rates observed in MABs isolated 
from intestinal segments may provide a mechanism to scale 
up to recreate large segments of intestinal tissue.
Previous studies of MABs as pericyte derivatives have 
proved difficult as there remain no unequivocal markers that 
allow for their identification. It is now assumed that peri-
cytes can be identified by expression of at least two of the 
pericytes markers including platelet-derived growth factor 
receptor β, neuron-glial antigen 2, alanyl aminopeptidase, 
alpha-smooth muscle actin and desmin [17]. Here we dem-
onstrate that murine MABs isolated from intestinal tissue 
express three known pericytes markers: neuron-glial antigen 
2, alkaline phosphatase and platelet-derived growth factor 
receptor β. Hence, to the best of our knowledge, this is the 
first study reporting the isolation of MABs from the neu-
romuscular wall of the small intestine. Further studies are 
needed to establish whether those progenitors could also be 
isolated from human specimens.
Thus, this proof-of-principle study lays the foundation 
for the further characterisation of MABs as a possible cell 
source for intestinal smooth muscle regeneration. The ability 
of deriving smooth muscle progenitors from the intestinal 
wall may help establishing gut tissue engineering as a viable 
treatment of conditions such as IF.
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